Cargando…
非小细胞肺癌免疫耐药机制及应对策略的研究进展
Immunotherapy has significantly improved clinical outcomes of non-small cell lung cancer (NSCLC), however, along with the popularization of immunotherapy, immune resistance has become an unavoidable problem. Immunotherapy can induce extensive cellular and molecular alterations in the tumor microenvi...
Autores principales: | JING, Yawan, ZENG, Hao, CHENG, Ruixin, TIAN, Panwen, LI, Yalun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial board of Chinese Journal of Lung Cancer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987066/ https://www.ncbi.nlm.nih.gov/pubmed/36792083 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.102.03 |
Ejemplares similares
-
肺癌免疫治疗耐药机制及应对策略
Publicado: (2021) -
MET基因改变的非小细胞肺癌靶向治疗耐药机制及治疗策略
por: LI, Shuzhan, et al.
Publicado: (2023) -
EGFR-TKI在非小细胞肺癌中耐药机制的研究进展
Publicado: (2013) -
ALK阳性非小细胞肺癌靶向治疗耐药机制及预后标志物的研究进展
Publicado: (2020) -
Venetoclax在慢性淋巴细胞白血病中的耐药机制及治疗策略
Publicado: (2020)